Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Disappearance of a strong triple positivity for antiphospholipid antibodies after treatment with anakinra.

Arnaud E, Soulier C, Gris JC.

Haematologica. 2019 Feb;104(2):e83-e84. doi: 10.3324/haematol.2018.205484. Epub 2018 Oct 25. No abstract available.

2.

Successful Pregnancy under Fibrinogen Substitution with Heparin and Aspirin in a Woman with Dysfibrinogenemia Revealed by Placental Abruption.

Bouvier S, Chea M, Ripart S, Hanss M, de Mazancourt P, Gris JC.

Thromb Haemost. 2018 Nov;118(11):2006-2008. doi: 10.1055/s-0038-1673615. Epub 2018 Oct 8.

PMID:
30296816
3.

Clinical value of automated fibrin generation markers in patients with septic shock: a SepsiCoag ancillary study.

Gris JC, Cochery-Nouvellon E, Bouvier S, Jaber S, Albanese J, Constantin JM, Orban JC, Morel J, Leone M, Deras P, Elotmani L, Lavigne-Lissalde G, Lefrant JY.

Br J Haematol. 2018 Nov;183(4):636-647. doi: 10.1111/bjh.15576. Epub 2018 Sep 11.

PMID:
30203833
4.

Analysis of C3 Gene Variants in Patients With Idiopathic Recurrent Spontaneous Pregnancy Loss.

Mohlin FC, Gros P, Mercier E, Gris JR, Blom AM.

Front Immunol. 2018 Aug 7;9:1813. doi: 10.3389/fimmu.2018.01813. eCollection 2018.

5.

Benefit of Risk Score-Guided Prophylaxis in Pregnant Women at Risk of Thrombotic Events: A Controlled Before-and-After Implementation Study.

Chauleur C, Gris JC, Laporte S, Chapelle C, Bertoletti L, Equy V, Gaucherand P, Bazan E, Dupuis O, Gallot D, Mismetti P; STRATHEGE Investigators and The STRATHEGE Group.

Thromb Haemost. 2018 Sep;118(9):1564-1571. doi: 10.1055/s-0038-1668524. Epub 2018 Aug 13.

PMID:
30103244
6.

Updated French practical guidelines on the management of dabigatran-treated patients.

Gouin-Thibault I, Gris JC.

Anaesth Crit Care Pain Med. 2018 Aug;37(4):311-312. doi: 10.1016/j.accpm.2018.07.004. No abstract available.

PMID:
30055827
7.

Complete remission of agranulocytosis after splenectomy in a variant form of T-cell large granular lymphocyte leukemia.

Lozano C, Brun S, Arnaud A, Gaulard P, Gonzalez S, Crouzet J, Gris JC.

Leuk Lymphoma. 2019 Jan;60(1):254-257. doi: 10.1080/10428194.2018.1471601. Epub 2018 Jul 2. No abstract available.

PMID:
29963929
8.

Reliability of hemostasis biomarkers is affected by time-dependent intra-patient variability.

Bouvier S, Bastide S, Chouirfa S, Nouvellon É, Mercier É, Bigot L, Lavigne G, Cayla G, Pérez-Martin A, Gris JC.

J Thromb Haemost. 2018 Jun 8. doi: 10.1111/jth.14198. [Epub ahead of print]

PMID:
29883046
9.

Angiogenic Factor Profiles in Pregnant Women With a History of Early-Onset Severe Preeclampsia Receiving Low-Molecular-Weight Heparin Prophylaxis.

Lecarpentier E, Gris JC, Cochery-Nouvellon E, Mercier E, Touboul C, Thadhani R, Karumanchi SA, Haddad B.

Obstet Gynecol. 2018 Jan;131(1):63-69. doi: 10.1097/AOG.0000000000002380.

PMID:
29215518
10.

THBD sequence variants potentially related to recurrent pregnancy loss.

Quintero-Ronderos P, Mercier E, Gris JC, Esteban-Perez C, Moreno-Ortiz H, Fonseca DJ, Lucena E, Vaiman D, Laissue P.

Reprod Biol Endocrinol. 2017 Dec 1;15(1):92. doi: 10.1186/s12958-017-0311-0.

11.

Novel genes and mutations in patients affected by recurrent pregnancy loss.

Quintero-Ronderos P, Mercier E, Fukuda M, González R, Suárez CF, Patarroyo MA, Vaiman D, Gris JC, Laissue P.

PLoS One. 2017 Oct 10;12(10):e0186149. doi: 10.1371/journal.pone.0186149. eCollection 2017.

12.

Peripartum bleeding management in a patient with CalDAG-GEFI deficiency.

Canault M, Saultier P, Fauré S, Poggi M, Nurden AT, Nurden P, Morange PE, Alessi MC, Gris JC.

Haemophilia. 2017 Nov;23(6):e533-e535. doi: 10.1111/hae.13352. Epub 2017 Oct 4. No abstract available.

PMID:
28976076
13.

Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study.

Raia-Barjat T, Prieux C, Gris JC, Chapelle C, Laporte S, Chauleur C.

J Matern Fetal Neonatal Med. 2019 Jan;32(2):248-257. doi: 10.1080/14767058.2017.1378325. Epub 2017 Sep 22.

PMID:
28889770
14.

Correction: Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study.

Di Bartolomeo A, Chauleur C, Tardy B, Piot M, Gris JC, Chapelle C, Noblot E, Laporte S, Raia-Barjat T.

PLoS One. 2017 Jul 12;12(7):e0181474. doi: 10.1371/journal.pone.0181474. eCollection 2017.

15.

Antiphospholipid antibodies are associated with positive screening for common mental disorders in women with previous pregnancy loss. The NOHA-PSY observational study.

Gris JC, Cyprien F, Bouvier S, Cochery-Nouvellon E, Lavigne-Lissalde G, Mercier E, Balducchi JP.

World J Biol Psychiatry. 2017 Jun 19:1-13. doi: 10.1080/15622975.2017.1333146. [Epub ahead of print]

PMID:
28532221
16.

Tissue factor pathway inhibitor for prediction of placenta-mediated adverse pregnancy outcomes in high-risk women: AngioPred study.

Di Bartolomeo A, Chauleur C, Gris JC, Chapelle C, Noblot E, Laporte S, Raia-Barjat T.

PLoS One. 2017 Mar 22;12(3):e0173596. doi: 10.1371/journal.pone.0173596. eCollection 2017. Erratum in: PLoS One. 2017 Jul 12;12 (7):e0181474.

17.

Antiphospholid antibodies and the risk of pregnancy complications.

Gris JC, Bouvier S, Nouvellon E, Lissalde-Lavigne G, Mercier E, Balducchi JP, Marès P.

Thromb Res. 2017 Mar;151 Suppl 1:S34-S37. doi: 10.1016/S0049-3848(17)30064-6. Review.

PMID:
28262231
18.

Evaluation of the non-compliance with grouping guidelines which may lead to "wrong blood in tube", an observational study and risk factor analysis.

Daurat A, Boudet E, Daurat G, Roger C, Gris JC, Tunez V, Gaste MC, Lefrant JY.

Transfus Clin Biol. 2017 Jun;24(2):47-51. doi: 10.1016/j.tracli.2017.01.003.

PMID:
28214244
19.

Obstetric antiphospholipid syndrome: early variations of angiogenic factors are associated with adverse outcomes.

Cochery-Nouvellon É, Mercier É, Bouvier S, Balducchi JP, Quéré I, Perez-Martin A, Mousty E, Letouzey V, Gris JC.

Haematologica. 2017 May;102(5):835-842. doi: 10.3324/haematol.2016.155184. Epub 2017 Jan 25.

20.

Tumor Necrosis Factor-Alpha and Pregnancy: Focus on Biologics. An Updated and Comprehensive Review.

Alijotas-Reig J, Esteve-Valverde E, Ferrer-Oliveras R, Llurba E, Gris JM.

Clin Rev Allergy Immunol. 2017 Aug;53(1):40-53. doi: 10.1007/s12016-016-8596-x. Review.

PMID:
28054230
21.

MACVIA-LR (Fighting Chronic Diseases for Active and Healthy Ageing in Languedoc-Roussillon): A Success Story of the European Innovation Partnership on Active and Healthy Ageing.

Bousquet J, Bourret R, Camuzat T, Augé P, Bringer J, Noguès M, Jonquet O, de la Coussaye JE, Ankri J, Cesari M, Guérin O, Vellas B, Blain H, Arnavielhe S, Avignon A, Combe B, Canovas G, Daien C, Dray G, Dupeyron A, Jeandel C, Laffont I, Laune D, Marion C, Pastor E, Pélissier JY, Galan B, Reynes J, Reuzeau JC, Bedbrook A, Granier S, Adnet PA, Amouyal M, Alomène B, Bernard PL, Berr C, Caimmi D, Claret PG, Costa DJ, Cristol JP, Fesler P, Hève D, Millot-Keurinck J, Morquin D, Ninot G, Picot MC, Raffort N, Roubille F, Sultan A, Touchon J, Attalin V, Azevedo C, Badin M, Bakhti K, Bardy B, Battesti MP, Bobia X, Boegner C, Boichot S, Bonnin HY, Bouly S, Boubakri C, Bourrain JL, Bourrel G, Bouix V, Bruguière V, Cade S, Camu W, Carre V, Cavalli G, Cayla G, Chiron R, Coignard P, Coroian F, Costa P, Cottalorda J, Coulet B, Coupet AL, Courrouy-Michel MC, Courtet P, Cros V, Cuisinier F, Danko M, Dauenhauer P, Dauzat M, David M, Davy JM, Delignières D, Demoly P, Desplan J, Dujols P, Dupeyron G, Engberink O, Enjalbert M, Fattal C, Fernandes J, Fouletier M, Fraisse P, Gabrion P, Gellerat-Rogier M, Gelis A, Genis C, Giraudeau N, Goucham AY, Gouzi F, Gressard F, Gris JC, Guillot B, Guiraud D, Handweiler V, Hayot M, Hérisson C, Heroum C, Hoa D, Jacquemin S, Jaber S, Jakovenko D, Jorgensen C, Kouyoudjian P, Lamoureux R, Landreau L, Lapierre M, Larrey D, Laurent C, Léglise MS, Lemaitre JM, Le Quellec A, Leclercq F, Lehmann S, Lognos B, Lussert CM, Makinson A, Mandrick K, Mares P, Martin-Gousset P, Matheron A, Mathieu G, Meissonnier M, Mercier G, Messner P, Meunier C, Mondain M, Morales R, Morel J, Mottet D, Nérin P, Nicolas P, Nouvel F, Paccard D, Pandraud G, Pasdelou MP, Pasquié JL, Patte K, Perrey S, Pers YM, Portejoie F, Pujol JL, Quantin X, Quéré I, Ramdani S, Ribstein J, Rédini-Martinez I, Richard S, Ritchie K, Riso JP, Rivier F, Robine JM, Rolland C, Royère E, Sablot D, Savy JL, Schifano L, Senesse P, Sicard R, Stephan Y, Strubel D, Tallon G, Tanfin M, Tassery H, Tavares I, Torre K, Tribout V, Uziel A, Van de Perre P, Venail F, Vergne-Richard C, Vergotte G, Vian L, Vialla F, Viart F, Villain M, Viollet E, Ychou M, Mercier J.

J Frailty Aging. 2016;5(4):233-241.

PMID:
27883170
22.

Association of FOXD1 variants with adverse pregnancy outcomes in mice and humans.

Laissue P, Lakhal B, Vatin M, Batista F, Burgio G, Mercier E, Santos ED, Buffat C, Sierra-Diaz DC, Renault G, Montagutelli X, Salmon J, Monget P, Veitia RA, Méhats C, Fellous M, Gris JC, Cocquet J, Vaiman D.

Open Biol. 2016 Oct;6(10). pii: 160109.

23.

Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications: A Randomized Controlled Trial.

Haddad B, Winer N, Chitrit Y, Houfflin-Debarge V, Chauleur C, Bages K, Tsatsaris V, Benachi A, Bretelle F, Gris JC, Bastuji-Garin S; Heparin-Preeclampsia (HEPEPE) Trial Investigators.

Obstet Gynecol. 2016 Nov;128(5):1053-1063.

PMID:
27741174
24.

Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials.

Rodger MA, Gris JC, de Vries JIP, Martinelli I, Rey É, Schleussner E, Middeldorp S, Kaaja R, Langlois NJ, Ramsay T, Mallick R, Bates SM, Abheiden CNH, Perna A, Petroff D, de Jong P, van Hoorn ME, Bezemer PD, Mayhew AD; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group.

Lancet. 2016 Nov 26;388(10060):2629-2641. doi: 10.1016/S0140-6736(16)31139-4. Epub 2016 Oct 6.

PMID:
27720497
25.

Relationship between Plasma D-Dimer Concentration and Three-Dimensional Ultrasound Placental Volume in Women at Risk for Placental Vascular Diseases: A Monocentric Prospective Study.

Fanget C, Chauleur C, Stadler A, Presles E, Varlet MN, Gris JC, Raia-Barjat T.

PLoS One. 2016 Jun 13;11(6):e0156593. doi: 10.1371/journal.pone.0156593. eCollection 2016.

26.

Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data.

Daurat A, Roger C, Gris J, Daurat G, Feissel M, Le Manach Y, Lefrant J, Muller L.

Transfusion. 2016 Jun;56(6):1295-303. doi: 10.1111/trf.13475. Epub 2016 Jan 26.

PMID:
26814984
27.

Antiphospholipid antibodies and the risk of severe and non-severe pre-eclampsia: the NOHA case-control study.

Marchetti T, de Moerloose P, Gris JC.

J Thromb Haemost. 2016 Apr;14(4):675-84. doi: 10.1111/jth.13257. Epub 2016 Mar 21.

28.

Placental growth factor and vascular endothelial growth factor serum levels in Tunisian Arab women with suspected preeclampsia.

Ben Ali Gannoun M, Bourrelly S, Raguema N, Zitouni H, Nouvellon E, Maleh W, Brahim Chemili A, Elfeleh R, Almawi W, Mahjoub T, Gris JC.

Cytokine. 2016 Mar;79:1-6. doi: 10.1016/j.cyto.2015.12.005. Epub 2015 Dec 15.

PMID:
26702929
29.

Diffusion tensor imaging in patients with obstetric antiphospholipid syndrome without neuropsychiatric symptoms.

Pereira FR, Macri F, Jackowski MP, Kostis WJ, Gris JC, Beregi JP, Mekkaoui C.

Eur Radiol. 2016 Apr;26(4):959-68. doi: 10.1007/s00330-015-3922-x. Epub 2015 Jul 23.

PMID:
26201292
30.

Association of common eNOS/NOS3 polymorphisms with preeclampsia in Tunisian Arabs.

Ben Ali Gannoun M, Zitouni H, Raguema N, Maleh W, Gris JC, Almawi W, Mahjoub T.

Gene. 2015 Sep 15;569(2):303-7. doi: 10.1016/j.gene.2015.05.072. Epub 2015 Jun 3.

PMID:
26049094
31.

Is there any future for low-molecular-weight heparin in the prevention of pregnancy loss?

Gris JC.

Ann Intern Med. 2015 May 5;162(9):658-9. doi: 10.7326/M15-0564. No abstract available.

PMID:
25938996
32.

Neuropsychiatric presentations of antiphospholipid antibodies.

Gris JC, Nobile B, Bouvier S.

Thromb Res. 2015 Feb;135 Suppl 1:S56-9. doi: 10.1016/S0049-3848(15)50445-3. Epub 2015 Feb 9. Review.

PMID:
25903539
33.

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial.

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

J Thromb Haemost. 2015 Apr;13(4):520-9. doi: 10.1111/jth.12844. Epub 2015 Mar 11.

34.

[Anesthetic management of severe or worsening postpartum hemorrhage].

Aya AG, Ducloy-Bouthors AS, Rugeri L, Gris JC.

J Gynecol Obstet Biol Reprod (Paris). 2014 Dec;43(10):1030-62. doi: 10.1016/j.jgyn.2014.10.001. Epub 2014 Nov 6. Review. French.

35.

Coagulation and mental disorders.

Hoirisch-Clapauch S, Nardi AE, Gris JC, Brenner B.

Rambam Maimonides Med J. 2014 Oct 29;5(4):e0036. doi: 10.5041/RMMJ.10170. eCollection 2014 Oct.

36.

Coagulation and placenta-mediated complications.

Greer IA, Aharon A, Brenner B, Gris JC.

Rambam Maimonides Med J. 2014 Oct 29;5(4):e0034. doi: 10.5041/RMMJ.10168. eCollection 2014 Oct.

37.

Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM).

Rodger MA, Langlois NJ, de Vries JI, Rey E, Gris JC, Martinelli I, Schleussner E, Ramsay T, Mallick R, Skidmore B, Middeldorp S, Bates S, Petroff D, Bezemer D, van Hoorn ME, Abheiden CN, Perna A, de Jong P, Kaaja R.

Syst Rev. 2014 Jun 26;3:69. doi: 10.1186/2046-4053-3-69.

38.

Regulatory T cells, maternal-foetal immune tolerance and recurrent miscarriage: new therapeutic challenging opportunities.

Alijotas-Reig J, Melnychuk T, Gris JM.

Med Clin (Barc). 2015 Mar 15;144(6):265-8. doi: 10.1016/j.medcli.2014.01.033. Epub 2014 Mar 22. Review.

PMID:
24667109
39.

Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?

Hoirisch-Clapauch S, Nardi AE, Gris JC, Brenner B.

Thromb Res. 2014 Jul;134(1):11-6. doi: 10.1016/j.thromres.2014.02.028. Epub 2014 Mar 5. Review.

PMID:
24661990
40.

Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies.

Bousquet J, Jorgensen C, Dauzat M, Cesario A, Camuzat T, Bourret R, Best N, Anto JM, Abecassis F, Aubas P, Avignon A, Badin M, Bedbrook A, Blain H, Bourdin A, Bringer J, Camu W, Cayla G, Costa DJ, Courtet P, Cristol JP, Demoly P, de la Coussaye JE, Fesler P, Gouzi F, Gris JC, Guillot B, Hayot M, Jeandel C, Jonquet O, Journot L, Lehmann S, Mathieu G, Morel J, Ninot G, Pelissier J, Picot MC, Radier-Pontal F, Robine JM, Rodier M, Roubille F, Sultan A, Wojtusciszyn A, Auffray C, Balling R, Barbara C, Cambon-Thomsen A, Chavannes NH, Chuchalin A, Crooks G, Dedeu A, Fabbri LM, Garcia-Aymerich J, Hajjam J, Melo Gomes E, Palkonen S, Piette F, Pison C, Price D, Samolinski B, Schunemann HJ, Sterk PJ, Yiallouros P, Roca J, Van de Perre P, Mercier J.

Curr Pharm Des. 2014;20(38):5928-44. Review.

PMID:
24641234
41.

The hidden activism of the misnamed.

Gris JC.

J Thromb Haemost. 2014 May;12(5):776-8. doi: 10.1111/jth.12563. No abstract available.

42.

Antithrombotic treatment for pregnancy complications: which path for the journey to precision medicine?

Greer IA, Brenner B, Gris JC.

Br J Haematol. 2014 Jun;165(5):585-99. doi: 10.1111/bjh.12813. Epub 2014 Mar 5. Review.

PMID:
24593333
43.

Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells.

Alijotas-Reig J, Llurba E, Gris JM.

Placenta. 2014 Apr;35(4):241-8. doi: 10.1016/j.placenta.2014.02.004. Epub 2014 Feb 14. Review.

PMID:
24581729
44.

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.

Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, Buonaiuto V, Jacobsen S, Zeher MM, Tarr T, Tincani A, Taglietti M, Theodossiades G, Nomikou E, Galeazzi M, Bellisai F, Meroni PL, Derksen RH, de Groot PG, Baleva M, Mosca M, Bombardieri S, Houssiau F, Gris JC, Quéré I, Hachulla E, Vasconcelos C, Fernández-Nebro A, Haro M, Amoura Z, Miyara M, Tektonidou M, Espinosa G, Bertolaccini ML, Khamashta MA; Euro-Phospholipid Project Group (European Forum on Antiphospholipid Antibodies).

Ann Rheum Dis. 2015 Jun;74(6):1011-8. doi: 10.1136/annrheumdis-2013-204838. Epub 2014 Jan 24.

45.

Diagnosis and management of obstetrical antiphospholipid syndrome: where do we stand?

Marchetti T, Cohen M, Gris JC, de Moerloose P.

Pol Arch Med Wewn. 2013;123(12):713-20. Review.

46.

Normal "high" thyroid stimulating hormone (TSH) levels and pregnancy rates in patients undergoing IVF with donor eggs.

Sordia-Hernandez LH, Morales Martinez A, Gris JM, Herrero J, Hernandez Uzcanga C, Merino M, Valdes O, Guerrero G.

Clin Exp Obstet Gynecol. 2014;41(5):517-20.

PMID:
25864250
47.

Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications.

Rodger MA, Carrier M, Le Gal G, Martinelli I, Perna A, Rey E, de Vries JI, Gris JC; Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group.

Blood. 2014 Feb 6;123(6):822-8. doi: 10.1182/blood-2013-01-478958. Epub 2013 Dec 19. Review.

48.

Polymorphisms of human placental alkaline phosphatase are associated with in vitro fertilization success and recurrent pregnancy loss.

Vatin M, Bouvier S, Bellazi L, Montagutelli X, Laissue P, Ziyyat A, Serres C, De Mazancourt P, Dieudonné MN, Mornet E, Vaiman D, Gris JC.

Am J Pathol. 2014 Feb;184(2):362-8. doi: 10.1016/j.ajpath.2013.10.024. Epub 2013 Dec 2.

PMID:
24296104
49.

Does the type of fluid affect rapidity of shock reversal in an anaesthetized-piglet model of near-fatal controlled haemorrhage? A randomized study.

Roger C, Muller L, Deras P, Louart G, Nouvellon E, Molinari N, Goret L, Gris JC, Ripart J, de La Coussaye JE, Lefrant JY.

Br J Anaesth. 2014 Jun;112(6):1015-23. doi: 10.1093/bja/aet375. Epub 2013 Nov 28.

50.

Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study.

Bouvier S, Cochery-Nouvellon E, Lavigne-Lissalde G, Mercier E, Marchetti T, Balducchi JP, Marès P, Gris JC.

Blood. 2014 Jan 16;123(3):404-13. doi: 10.1182/blood-2013-08-522623. Epub 2013 Nov 7.

Supplemental Content

Support Center